DNA GTx’s Hereditary Panel A screens for germline variants across 113 genes known to be associated with the most common types of cancer that could increase cancer risk. This comprehensive panel identifies inherited genetic mutations that may significantly increase the risk of developing cancers such as breast, ovarian, colorectal, endometrial, pancreatic, and others.
Early identification of at-risk individuals enables proactive clinical decisions, including surveillance, preventive interventions, and personalized care planning for patients and their families.
Yes. A healthcare provider must order this test. They’ll review your medical and family history, help you understand the results, and guide you on the next steps if a risk is found.
Let’s Decode the Future of Health — Together
Get in touch today — let’s start a conversation that could change lives
*All information is handled with strict confidentiality.
Find Answers Today
Early detection saves lives
*All information is handled with strict confidentiality.